Synaptogenix to Present at Sachs 5th Annual Neuroscience Innovation Forum
/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...
Daniel Alkon Robert Weinstein Exchange Commission Drug Administration Sachs Forum Prnewswire Synaptogenix Inc
Source: prnewswire.com